Parisa Fallahtafti

MD-MPH @TehUofMed | Researcher

[Parisa Fallahtafti @pfallahtafti]

@AmirBehnoush @AHAScience Congrats Amirhossein!

[Parisa Fallahtafti @pfallahtafti]

@Melika_HSH 😍😍😍

[Parisa Fallahtafti @pfallahtafti]

@AlilouSanam @nyugsom_ccrs Congrats Sanam jan!

[HeartFirst @HeartFirstNow]

This emerging data on young adult cardiovascular trends deserves attention. We need a vetted global directory to connect at-risk individuals with credible organizations. Join us in creating solutions.

[Parisa Fallahtafti @pfallahtafti]

@AlilouSanam Thank you Sanam jan!

[Parisa Fallahtafti @pfallahtafti]

Check out our new paper on global cardiovascular deaths linked to high BMI!

[AJPC @AJPCardio]

🌍 A global look-back (1990–2021) + projections forward: rising cardiovascular mortality linked to high BMI. Obesity = major threat to heart health worldwide.

🔗 https://t.co/Pijr22qIc0

@khurramn1

#Obesity #HeartHealth #CVDTrends #Prevention

[Parisa Fallahtafti @pfallahtafti]

@SinaRsh Thank you so much Sina!

[Parisa Fallahtafti @pfallahtafti]

@SinaRsh @JACCJournals Congrats Sina!

[Parham Sadeghipour @psadeghipour]

#COATEDAIR closer & closer to 🏁.
2x2 factorial RCT in ASCVD:
🔎1 Coated vs plain ASA
🔎2 Hybrid vs routine strategy ⬇ CVD of 😷💨
🙏🏻to pts trust & devotion of all investigators
https://t.co/gOSeKYn56K
@bbikdeli @AzitaTalasaz

[Parisa Fallahtafti @pfallahtafti]

@Amirali_karimii @TehUofMed @MDAndersonNews Good luck Amirali 🤞🏻

[Parisa Fallahtafti @pfallahtafti]

@SabaMalekiMD 😍😍😍

[Parham Dastjerdi @DastjerdiParham]

📢 New Publication!

Our meta-analysis in the American Journal of Nephrology (IF 4.3, Q1) examines:

Intensive vs. Less Intensive Blood Pressure Control in CKD (stage 3+)
🔍 11 RCTs | >8,000 patients
📊 No significant benefit on renal outcomes or all-cause mortality

[Parisa Fallahtafti @pfallahtafti]

@MahsaDolatshah1 @RSNA @cyrusraji @WashUMedMIR @RSNATrainees Congrats Mahsa jan!😍🎉

[Parisa Fallahtafti @pfallahtafti]

@SinaRsh @GregoryPiazza4 @NEJM Many congrats Sina!

[Cardiovascular Diseases Research Institute @TUMS_CVDRI]

#MetaAnalysis of 11 (#RCTs, n=8,740): Intensive #BloodPressure control in #ChronicKidneyDisease (#CKD, stage 3+) shows no significant benefit on mortality or renal outcomes vs. standard control.
#Nephrology #Hypertension @Jishanth44 @MichaelGNanna https://t.co/2IF1f3avta

[Cardiovascular Diseases Research Institute @TUMS_CVDRI]

#AI improves prediction of outcomes after #TranscatheterAorticValveReplacement (#TAVR), showing high accuracy in identifying risks and complications. #Cardiology @sina_kazemian @SabaMalekiMD @pfallahtafti @Naderian_mr @adnanalkhouli @yasjenab https://t.co/amT862vY74

[Cardiovascular Diseases Research Institute @TUMS_CVDRI]

#Stroke cases and deaths in #NorthAfrica and the #MiddleEast doubled from 1990 to 2021, despite declines in age-standardized rates. Key risks include high blood pressure, air pollution, and LDL cholesterol. #GlobalHealth #PublicHealth @pfallahtafti
https://t.co/wi4Cwpazfh

[Parisa Fallahtafti @pfallahtafti]

@mmrzbabaei @HTavoli @MasihTajdini Congrats! 🎊

[JACC Journals @JACCJournals]

First sham-RCT of thigh-length elastic compression stockings in recurrent vasovagal syncope (VVS) found no benefit for recurrence or VVS-free survival. Routine use not supported https://t.co/dTK6dzFiLp #JACC

[Parisa Fallahtafti @pfallahtafti]

@MahsaDolatshah1 @TheNRMP Congrats Mahsa jan! 😍